Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Nodular Lymphocyte Predominant Hodgkin Lymphoma With Aberrant Immunophenotype or Variant Histopathology: Insights From Case Series of Three Patients

GURVIN CHANDER, HANSINI DASSANAYAKE, MARIA KAPAROU, MARIA AHMED, BHUVAN KISHORE, EMMANOUIL NIKOLOUSIS and ALEXANDROS KANELLOPOULOS
Anticancer Research August 2021, 41 (8) 4017-4020; DOI: https://doi.org/10.21873/anticanres.15200
GURVIN CHANDER
1Haematology Department, Heartlands Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HANSINI DASSANAYAKE
1Haematology Department, Heartlands Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MARIA KAPAROU
1Haematology Department, Heartlands Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MARIA AHMED
1Haematology Department, Heartlands Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
BHUVAN KISHORE
1Haematology Department, Heartlands Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
EMMANOUIL NIKOLOUSIS
1Haematology Department, Heartlands Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ALEXANDROS KANELLOPOULOS
1Haematology Department, Heartlands Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, U.K.
2Haematology Department and Bone Marrow Transplantation Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Alexandros.kanellopoulos{at}nhs.net
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 41 no. 8 4017-4020
DOI 
https://doi.org/10.21873/anticanres.15200
PubMed 
34281867

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received June 6, 2021
  • Revision received June 27, 2021
  • Accepted June 28, 2021
  • Published online July 19, 2021.

Copyright & Usage 
Copyright © 2021 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Author Information

  1. GURVIN CHANDER1,
  2. HANSINI DASSANAYAKE1,
  3. MARIA KAPAROU1,
  4. MARIA AHMED1,
  5. BHUVAN KISHORE1,
  6. EMMANOUIL NIKOLOUSIS1 and
  7. ALEXANDROS KANELLOPOULOS1,2⇑
  1. 1Haematology Department, Heartlands Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, U.K.
  2. 2Haematology Department and Bone Marrow Transplantation Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, U.K.
  1. Correspondence to: Alexandros Kanellopoulos, Haematology Department and Bone Marrow Transplantation Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, U.K. E-mail: Alexandros.kanellopoulos{at}nhs.net
View Full Text

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 41, Issue 8
August 2021
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Nodular Lymphocyte Predominant Hodgkin Lymphoma With Aberrant Immunophenotype or Variant Histopathology: Insights From Case Series of Three Patients
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
8 + 4 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Nodular Lymphocyte Predominant Hodgkin Lymphoma With Aberrant Immunophenotype or Variant Histopathology: Insights From Case Series of Three Patients
GURVIN CHANDER, HANSINI DASSANAYAKE, MARIA KAPAROU, MARIA AHMED, BHUVAN KISHORE, EMMANOUIL NIKOLOUSIS, ALEXANDROS KANELLOPOULOS
Anticancer Research Aug 2021, 41 (8) 4017-4020; DOI: 10.21873/anticanres.15200

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Nodular Lymphocyte Predominant Hodgkin Lymphoma With Aberrant Immunophenotype or Variant Histopathology: Insights From Case Series of Three Patients
GURVIN CHANDER, HANSINI DASSANAYAKE, MARIA KAPAROU, MARIA AHMED, BHUVAN KISHORE, EMMANOUIL NIKOLOUSIS, ALEXANDROS KANELLOPOULOS
Anticancer Research Aug 2021, 41 (8) 4017-4020; DOI: 10.21873/anticanres.15200
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Case Report
    • Discussion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Efficacy of Platinum-based Chemotherapy for Platinum-sensitive Recurrent Ovarian Cancer During PARP Inhibitor Treatment: A Multicenter Retrospective Study
  • Uniformity Between Serological Biomarker Test, Esophago-gastro-duodenoscopy and Biopsy Histology in Triage of Upper Abdominal Symptoms in Gastroscopy Referral Patients
  • Renal Function With Enfortumab Vedotin in Metastatic Urothelial Carcinoma: A Multicenter Retrospective Study in Japan
Show more Clinical Studies

Similar Articles

Keywords

  • Aberrant immunophenotype
  • nodular lymphocyte predominant Hodgkin lymphoma
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire